Literature DB >> 35662128

Inflammatory Animal Models of Parkinson's Disease.

Juan García-Revilla1,2,3, Antonio J Herrera2,3, Rocío M de Pablos2,3, José Luis Venero2,3.   

Abstract

Accumulating evidence suggests that microglia and peripheral immune cells may play determinant roles in the pathogenesis of Parkinson's disease (PD). Consequently, there is a need to take advantage of immune-related models of PD to study the potential contribution of microglia and peripheral immune cells to the degeneration of the nigrostriatal system and help develop potential therapies for PD. In this review, we have summarised the main PD immune models. From a historical perspective, we highlight first the main features of intranigral injections of different pro-inflammogens, including lipopolysaccharide (LPS), thrombin, neuromelanin, etc. The use of adenoviral vectors to promote microglia-specific overexpression of different molecules in the ventral mesencephalon, including α-synuclein, IL-1β, and TNF, are also presented and briefly discussed. Finally, we summarise different models associated with peripheral inflammation whose contribution to the pathogenesis of neurodegenerative diseases is now an outstanding question. Illustrative examples included systemic LPS administration and dextran sulfate sodium-induced colitis in rodents.

Entities:  

Keywords:  Parkinson’s disease; adenovirus; animal models; dextran sulfate sodium; inflammation; lipopolysaccharide; microglia; substantia nigra; thrombin

Mesh:

Substances:

Year:  2022        PMID: 35662128      PMCID: PMC9535574          DOI: 10.3233/JPD-213138

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.520


  169 in total

1.  Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.

Authors:  U Ungerstedt; T Ljungberg; G Steg
Journal:  Adv Neurol       Date:  1974

Review 2.  Reverse engineering Lewy bodies: how far have we come and how far can we go?

Authors:  Mohamed Bilal Fares; Somanath Jagannath; Hilal A Lashuel
Journal:  Nat Rev Neurosci       Date:  2021-01-11       Impact factor: 34.870

3.  H2S prevents peripheral immune cell invasion, increasing [Ca2+]i and excessive phagocytosis following hypoxia-ischemia injury in neonatal mice.

Authors:  Tingting Li; Xili Chu; Danqing Xin; Hongfei Ke; Shuhan Wang; Dexiang Liu; Wenqiang Chen; Zhen Wang
Journal:  Biomed Pharmacother       Date:  2021-02-01       Impact factor: 6.529

4.  A rat model of Parkinson's disease induced by Japanese encephalitis virus.

Authors:  A Ogata; K Tashiro; S Nukuzuma; K Nagashima; W W Hall
Journal:  J Neurovirol       Date:  1997-04       Impact factor: 2.643

5.  Degeneration of dopaminergic neurons induced by thrombin injection in the substantia nigra of the rat is enhanced by dexamethasone: role of monoamine oxidase enzyme.

Authors:  Sandro Argüelles; Antonio J Herrera; Eloisa Carreño-Müller; Rocío M de Pablos; Ruth F Villarán; Ana M Espinosa-Oliva; Alberto Machado; Josefina Cano
Journal:  Neurotoxicology       Date:  2009-12-05       Impact factor: 4.294

Review 6.  Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases.

Authors:  Antonio J Herrera; Ana M Espinosa-Oliva; Maria J Oliva-Martin; Alejandro Carrillo-Jimenez; Jose L Venero; Rocio M de Pablos
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

7.  Orally Administered DHA-Enriched Phospholipids and DHA-Enriched Triglyceride Relieve Oxidative Stress, Improve Intestinal Barrier, Modulate Inflammatory Cytokine and Gut Microbiota, and Meliorate Inflammatory Responses in the Brain in Dextran Sodium Sulfate Induced Colitis in Mice.

Authors:  Hongxia Che; Hongyan Li; Lin Song; Xiufang Dong; Xihong Yang; Tiantian Zhang; Yuming Wang; Wancui Xie
Journal:  Mol Nutr Food Res       Date:  2021-06-18       Impact factor: 5.914

8.  Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence.

Authors:  A Machado; A J Herrera; J L Venero; M Santiago; R M De Pablos; R F Villarán; A M Espinosa-Oliva; S Argüelles; M Sarmiento; M J Delgado-Cortés; R Mauriño; J Cano
Journal:  Parkinsons Dis       Date:  2011-04-13

9.  Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.

Authors:  Vanesa Sanchez-Guajardo; Fabia Febbraro; Deniz Kirik; Marina Romero-Ramos
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

Review 10.  TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.

Authors:  Melissa K McCoy; Malú G Tansey
Journal:  J Neuroinflammation       Date:  2008-10-17       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.